A pilot study of long-acting octreotide for symptomatic malignant ascites

Secondary title: 
T2 - Oncology
Short title: 
A pilot study of long-acting octreotide for symptomatic malignant ascites
Authors: 
Jatoi, A.
Nieva, J. J.
Qin, R.
Loprinzi, C. L.
Wos, E. J.
Novotny, P. J.
Moore, D. F.
Mowat, R. B.
Bechar, N.
Pajon, E. R.
Hartmann, L. C.
Start page: 
315-20
Annotations: 
Type B, Priority 5,
Year: 
2012
Accession number: 
CN-00840365
Database: 
CENTRAL Issue 4 2014
Number: 
M1 - 6
ID: 
3032
DOI: 
10.1159/000337246 (link)
Notes: 
N1 - Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Key words: 
Ascites [drug therapy] [metabolism] [pathology]
Octreotide [administration & dosage] [adverse effects]
Peritoneal Neoplasms [drug therapy] [metabolism] [pathology]
Pilot Projects
Quality of Life
Vascular Endothelial Growth Factor A [antagonists & inhibitors] [metabolism]
Adult[checkword]
Aged[checkword]
Aged, 80 and over[checkword]
Female[checkword]
Humans[checkword]
Male[checkword]
Middle Aged[checkword]
Types of evidence: 
Type B
Priorities of Care: 
Priority 5: Plan and do